Qnasl beclomethasone dipropionate nasal aerosol regulatory update

FDA approved an sNDA from Teva for 40 µg inhaled Qnasl beclomethasone dipropionate nasal aerosol to treat seasonal and perennial allergic rhinitis in patients ages 4-11 years. Teva said the dose will ...